Literature DB >> 28231055

The role of extracellular vesicle microRNAs in cancer biology.

Ryou-U Takahashi1, Marta Prieto-Vila1, Ai Hironaka1, Takahiro Ochiya1.   

Abstract

microRNAs (miRNAs) constitute a large family of small, approximately 20-22 nucleotide non-coding RNAs that regulate the expression of target genes, mainly at the post-transcriptional level. Multiple studies report that miRNAs are involved in homeostatic maintenance and that aberrant expression of miRNAs is often observed in various types of diseases, including cancer. In cancer biology, miRNAs exert functional roles in tumor initiation, drug resistance, and metastasis. miRNAs are also secreted through small vesicles called exosomes, which are endosome-derived vesicles derived from various cell types including immune and tumor cells. In addition to cellular miRNAs (ce-miRNAs), secreted miRNAs (se-miRNAs) play important roles in cancer development and metastasis. Therefore, se-miRNAs in body fluids have been investigated as a promising biomarkers and therapeutic targets for cancer treatment. In this review, we summarize the current knowledge of miRNA functions in cancer development and discuss the potential clinical applications of se-miRNAs, e.g. as diagnostic markers and therapeutic targets.

Entities:  

Keywords:  biomarker; cancer; diagnosis; exosome; microRNA; therapy

Mesh:

Substances:

Year:  2017        PMID: 28231055     DOI: 10.1515/cclm-2016-0708

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  37 in total

Review 1.  Extracellular membrane vesicles in the three domains of life and beyond.

Authors:  Sukhvinder Gill; Ryan Catchpole; Patrick Forterre
Journal:  FEMS Microbiol Rev       Date:  2019-05-01       Impact factor: 16.408

2.  Exosomes: recruits for tumour surveillance?

Authors:  Francesco Pezzella
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 3.  Potential Role of Extracellular Vesicles in the Pathophysiology of Drug Addiction.

Authors:  P S S Rao; Kelly O'Connell; Thomas Kyle Finnerty
Journal:  Mol Neurobiol       Date:  2018-01-23       Impact factor: 5.590

4.  A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic methamphetamine use disorder.

Authors:  Subhash Chand; Austin Gowen; Mason Savine; Dalia Moore; Alexander Clark; Wendy Huynh; Niming Wu; Katherine Odegaard; Lucas Weyrich; Rick A Bevins; Howard S Fox; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  J Extracell Vesicles       Date:  2021-12

5.  Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer.

Authors:  Caroline Izak Cuzziol; Ludimila Leite Marzochi; Vitória Scavacini Possebon; Rosa Sayoko Kawasaki-Oyama; Marlon Fraga Mattos; Vilson Serafim Junior; Letícia Antunes Muniz Ferreira; Érika Cristina Pavarino; Márcia Maria Urbanin Castanhole-Nunes; Eny Maria Goloni-Bertollo
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

6.  UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis.

Authors:  Xiyin Huang; Juanyong Pan; Gaoxiong Wang; Tiancong Huang; Chengzong Li; Yanjun Wang; Xinfeng Li
Journal:  Cell Cycle       Date:  2021-10-06       Impact factor: 5.173

7.  MicroRNA 21 Elicits a Pro-inflammatory Response in Macrophages, with Exosomes Functioning as Delivery Vehicles.

Authors:  Radha Madhyastha; Harishkumar Madhyastha; Queen Intan Nurrahmah; Bethasiwi Purbasari; Masugi Maruyama; Yuichi Nakajima
Journal:  Inflammation       Date:  2021-01-26       Impact factor: 4.092

8.  MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.

Authors:  Feng Liu; Dalong Song; Yanhu Wu; Xiang Liu; Jinfu Zhu; Yihu Tang
Journal:  Thorac Cancer       Date:  2017-08-26       Impact factor: 3.500

9.  IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.

Authors:  Giusy Lombardo; Maddalena Gili; Cristina Grange; Claudia Cavallari; Patrizia Dentelli; Gabriele Togliatto; Daniela Taverna; Giovanni Camussi; Maria Felice Brizzi
Journal:  Oncogene       Date:  2017-12-14       Impact factor: 9.867

10.  miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.

Authors:  Quanbo Ji; Xiaojie Xu; Qi Song; Yameng Xu; Yanhong Tai; Stuart B Goodman; Wenzhi Bi; Meng Xu; Shunchang Jiao; William J Maloney; Yan Wang
Journal:  Mol Ther       Date:  2018-03-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.